Together with the finding of potent acceleration of c-MYC driven lymphoma development by BCL-2 over-expression (see above; [26]), this indicated that inhibiting cell death promoted tumorigenesis by keeping alive cells sustaining stress from oncogene activation, thereby facilitating subsequent steps in neoplastic transformation, including enabling the acquisition of further oncogenic mutations. Here, BCL2 is linked to lymphoma.